CASADEI, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 735
EU - Europa 547
AS - Asia 50
AF - Africa 8
SA - Sud America 2
Totale 1.342
Nazione #
US - Stati Uniti d'America 725
FR - Francia 310
IT - Italia 120
DE - Germania 37
IE - Irlanda 21
IN - India 15
GB - Regno Unito 14
AE - Emirati Arabi Uniti 12
CN - Cina 12
SE - Svezia 11
BG - Bulgaria 9
CA - Canada 7
ZA - Sudafrica 6
FI - Finlandia 5
NL - Olanda 5
VN - Vietnam 5
CH - Svizzera 3
MX - Messico 3
RU - Federazione Russa 3
JP - Giappone 2
PL - Polonia 2
TR - Turchia 2
UA - Ucraina 2
AT - Austria 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
NG - Nigeria 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.342
Città #
Ashburn 245
Paris 56
Fairfield 53
Santa Cruz 50
Buffalo 25
Seattle 22
Bologna 21
Dublin 21
Woodbridge 17
Boardman 16
Houston 16
Chicago 14
Wilmington 14
Cambridge 12
Milan 12
Rome 12
New York 9
Sofia 9
Southend 9
Stockholm 9
Bremen 8
Dallas 8
Beijing 7
Chennai 6
Ann Arbor 5
Los Angeles 5
Ottawa 5
Helsinki 4
Redmond 4
San Diego 4
Amsterdam 3
Dong Ket 3
Hyderabad 3
Las Vegas 3
Milpitas 3
Modena 3
Mountain View 3
Muizenberg 3
Phoenix 3
Pizzo 3
Tappahannock 3
Basel 2
Bergamo 2
Bitetto 2
Brooklyn 2
Catania 2
Clearwater 2
Crugers 2
Imola 2
Jacksonville 2
Johannesburg 2
Kaiserslautern 2
Mexico City 2
Monza 2
Mumbai 2
Naples 2
Nuremberg 2
Palo Alto 2
Provo 2
Rimini 2
Saint Petersburg 2
Savignano sul Rubicone 2
Shanghai 2
Trento 2
Triggiano 2
Vicenza 2
Warsaw 2
Abidjan 1
Athens 1
Bari 1
Bengaluru 1
Bogotá 1
Brandenburg 1
Brockport 1
Bursa 1
Camden 1
Castel Maggiore 1
Castellammare Di Stabia 1
Cedar Knolls 1
Cesenatico 1
Chieti 1
Cincinnati 1
Cislago 1
Columbus 1
Como 1
Copenhagen 1
Copparo 1
Council Bluffs 1
Curno 1
Delhi 1
Fleming Island 1
Florence 1
Forlì 1
Frankfurt Am Main 1
Genova 1
Grenoble 1
Groningen 1
Guidonia Montecelio 1
Hamilton 1
Henderson 1
Totale 816
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years, file e1dcb335-285c-7715-e053-1705fe0a6cc9 274
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma, file 408481ab-e2a7-45e5-9af7-2c7cf09940f9 256
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients, file e1dcb333-91a9-7715-e053-1705fe0a6cc9 105
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue, file e1dcb334-1ed2-7715-e053-1705fe0a6cc9 102
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience, file e1dcb333-6fd6-7715-e053-1705fe0a6cc9 89
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results, file e1dcb334-f6ec-7715-e053-1705fe0a6cc9 80
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma, file e1dcb337-8f97-7715-e053-1705fe0a6cc9 77
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series, file e1dcb335-45ef-7715-e053-1705fe0a6cc9 68
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study, file e1dcb33a-234c-7715-e053-1705fe0a6cc9 55
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience, file e1dcb33a-3227-7715-e053-1705fe0a6cc9 41
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma, file e1dcb336-6ee1-7715-e053-1705fe0a6cc9 40
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy, file 71f06c47-d85a-4656-8b91-af7c55679358 23
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity, file dd104b0e-942d-40b0-8e2e-3957bbf4cf61 19
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival, file 8230c729-0b80-415d-aec7-f71c307653ed 17
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, file ced17cde-11fa-421f-89df-0fcc9a20ac12 14
Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors, file e1dcb33a-0f7b-7715-e053-1705fe0a6cc9 13
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study, file e96c1617-928a-4e66-ba46-a166772e9dd6 12
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, file 9dcb8094-999a-4e2e-8da2-83f6eb289375 11
Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience, file 9b1013e6-644a-4333-b38f-d5ab42aec7a9 9
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report, file 3fe60275-29c6-4d86-b461-ad84fc79cc20 8
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma, file bae53c4b-6b41-43f1-80b7-448a1a9afd5a 8
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma, file 6ac2510c-7bf9-4396-a634-6c6a014d0db0 7
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study, file a97b4c39-6b68-4e99-bf2f-5efb79db51e2 6
Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients with Relapsed/Refractory B-Cell Hodgkin Lymphoma: The MICRO-Linf Study, file 36a0734b-0320-4412-93b8-3c2a36633321 4
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi, file c85df553-818f-4b13-a930-b044e2c9e6bd 4
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients, file e528260a-8c2e-4cc3-a1d1-3fde7709f459 4
Impressive continuous complete response after mogamulizumab in a heavily pretreated Sézary syndrome patient, file 0898ff18-67f6-4a8d-b21f-5c8a986b72fe 2
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, file 6753c243-a23e-45d0-b672-40573b4dc478 2
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study, file eef4c0f5-68c1-4a44-8d52-ad2b12f6eeda 2
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia, file 1df23b89-7771-4e72-a788-03db75e2ee2f 1
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost!, file 2b38a396-6203-4e0e-be75-35666a5e8e7b 1
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, file 67e0c7ab-54e3-445a-bbc4-28b9125a9932 1
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers, file 799fb93e-05df-41f2-8ce5-3a2ded7b60ff 1
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia, file 7e7a7ef0-9bc1-482f-8e94-22dd86a19080 1
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, file 9a9ef06f-6f7e-405e-aadc-be15138bbda0 1
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost!, file 9c3224ee-97de-4dbc-89e3-000bd8e6eb13 1
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity, file a280f07d-e82d-4b3a-8cb6-c68464024478 1
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection, file a8a5056e-e087-4620-a5fd-a71aeaed4b5a 1
Spontaneous remission of follicular lymphoma, file e1dcb334-8dd9-7715-e053-1705fe0a6cc9 1
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies, file e1dcb334-9257-7715-e053-1705fe0a6cc9 1
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-cell Lymphoma, Leg-type: A Case Report, file f4a7e32e-b4d1-44cc-9d2d-cf7c5f7f6957 1
Totale 1.364
Categoria #
all - tutte 4.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202082 0 0 0 0 3 8 11 13 21 14 8 4
2020/2021119 10 12 10 3 6 10 10 15 14 8 14 7
2021/2022190 6 16 8 5 22 6 7 9 7 2 68 34
2022/2023234 4 8 51 39 9 21 8 16 25 14 31 8
2023/2024739 24 10 20 47 17 252 259 57 32 21 0 0
Totale 1.364